【=WuXi Biologics and Earendil Labs Reach Strategic Partnership=

WuXi Biologics and the biotechnology company Earendil Labs today jointly announced that the two sides have signed a strategic cooperation agreement. WuXi Biologics will provide end-to-end development and manufacturing services for multiple bispecific/multispecific antibodies and antibody-drug conjugates (ADC) in the Earendil Labs pipeline for the treatment of autoimmune diseases, tumors, and other conditions.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin